Apple Tree Partners
Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Business Model:
Revenue: $12.2M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Apple Tree Partners Information
Geographic Data
Address: 230 Park Avenue Suite 2800
City: New York
State: NY
Zip: 10169
Country: US
Financial Info
Stage:
Raised Last:
$5M
Raised Total:$5M
Social
Twitter
Linkedin
Crunchbase
Metrics
6,950,056Website Global Rank
680Website Monthly Traffic
Twitter Followers
Description
ATP, a global leader in life sciences venture capital, is developing the next generation of transformative biotechnology companies. ATP creates science-based companies starting with assets at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines. The firm provides flexible capital, strategic insight, and operational resources to build sustainable, research-driven enterprises. ATP invests in its portfolio companies from seed stage through IPO and beyond and supports their management teams in strategic transactions and synergistic business combinations.
Contact Phone:
+16174012100
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2021 | Intergalactic Therapeutics | Series A | 0 |
| 1/2021 | Aulos Bioscience | Series A | 0 |
| 7/2020 | Nine Square Therapeutics | Series A | 50M |
| 8/2009 | Gloucester Pharmaceuticals | Series D | 29M |
| 6/2018 | Akero Therapeutics | Series A | 65M |
| 2/2014 | Aurinia Pharmaceuticals | Post-IPO Equity | 52M |
| 6/2015 | Cure Forward | Venture Round | 15M |
| 7/2016 | VytronUS | Series C | 49M |
| 11/2021 | Marengo Therapeutics | Venture Round | 80M |
| 3/2016 | Syntimmune | Series A | 10M |
| 1/2018 | Braeburn | Debt Financing | 0 |
| 2/2021 | Replicate Bioscience | Seed Round | 0 |
| 10/2022 | Ascidian Therapeutics | Series A | 50M |
| 6/2007 | Aileron Therapeutics | Series B | 7M |
| 9/2022 | Galvanize Therapeutics | Series B | 0 |
| 4/2014 | Tendyne Holdings | Series C | 25M |
| 9/2021 | Replicate Bioscience | Series A | 40M |
| 1/2021 | Ascidian Therapeutics | Seed Round | - |
| 6/2017 | Syntimmune | Series B | 50M |
| 2/2016 | QualDerm Partners | Venture Round | 31.8M |
| 12/2019 | Limelight Bio | Venture Round | 75M |
| 4/2008 | Aileron Therapeutics | Series C | 10.5M |
| 1/2021 | Intergalactic Therapeutics | Seed Round | - |
| 1/2018 | Stoke Therapeutics | Series A | 40M |
| 6/2009 | Aileron Therapeutics | Series D | 40M |
| 3/2021 | Galaxy Medical | Series A | 10M |
| 10/2014 | Aileron Therapeutics | Series E | 33M |
| 8/2020 | Chinook Therapeutics | Private Placement | 106M |
| 1/2021 | Marengo Therapeutics | Seed Round | - |
| 2/2016 | Corvidia | Series A | 26M |
| 11/2016 | Syntimmune | Series A | 8M |
| 9/2011 | Eledon Pharmaceuticals | Series D | 23M |
| 12/2018 | Bellus Health | Post-IPO Equity | 26M |
| 8/2014 | Dermira | Series C | 51M |
| 4/2018 | Corvidia | Series B | 60M |
| 10/2020 | Galaxy Medical | Seed Round | 8M |
| 5/2013 | Eledon Pharmaceuticals | Series E | 35.5M |
| 12/2021 | Adendra Therapeutics | Series A | 53M |
| 3/2000 | Cyrano Sciences | Venture Round | 23M |
| 9/2016 | Rox Medical | Series E | 40M |
| 10/2014 | Syntimmune | Series A | 8M |
| 10/2018 | Stoke Therapeutics | Series B | 90M |
| 11/2020 | Nereid | Series A | 50M |
| 7/2020 | Initial Therapeutics | Seed Round | 3.8M |
| 1/2013 | Aileron Therapeutics | Series D | 12M |
| 12/2006 | Aileron Therapeutics | Series A | 7M |
| 10/2004 | Gloucester Pharmaceuticals | Series B | 29M |
| 8/2019 | Chinook Therapeutics | Series A | 65M |
| 1/2023 | Aethon Therapeutics | Series A | 30M |
| 11/2013 | Aileron Therapeutics | Series E | 30M |
| 7/2014 | Cerecor | Series B | 32M |
| 11/2019 | Gala Therapeutics | Venture Round | 42.5M |
| 6/2009 | Eledon Pharmaceuticals | Series D | 22M |
| 6/2007 | Eledon Pharmaceuticals | Series B | 9.3M |
| 1/2018 | Elstar Therapeutics | Series A | 39M |
| 10/2014 | VytronUS | Series B | 31.6M |
| 12/2021 | Adendra Therapeutics | Series A | 0 |
| 11/2021 | Marengo Therapeutics | Series B | 0 |
| 10/2021 | Intergalactic Therapeutics | Series A | 0 |
| 9/2021 | Replicate Bioscience | Series A | 0 |
| 3/2021 | Galaxy Medical | Series A | 0 |
| 2/2021 | Replicate Bioscience | Seed Round | 0 |
| 1/2021 | Aulos Bioscience | Series A | 0 |
| 1/2021 | Intergalactic Therapeutics | Seed Round | - |
| 1/2021 | Marengo Therapeutics | Seed Round | - |
| 1/2021 | Ascidian Therapeutics | Seed Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
